$28.31 +0.45 (%) Dynavax Technologies Corp - NASDAQ

Sep. 4, 2015 | 04:00 PM

Partner Headlines

  1. Dynavax to Participate in Two Upcoming Investor Conferences

    GuruFocus | Sep. 4, 2015 | 00:03AM EST
  2. Dynavax Reports Second Quarter 2015 Financial Results

    GuruFocus | Aug. 8, 2015 | 00:02AM EST
  3. Benzinga's Volume Movers

    Benzinga | Jul. 22, 2015 | 10:33AM EST
  4. Dynavax Announces Third Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM) and Updates Financial Status

    Benzinga | Jul. 9, 2015 | 09:03AM EST
  5. Mid-Afternoon Market Update: Dow Dips Over 100 Points; Crude Oil Tumbles 5.5%

    Benzinga | Jul. 6, 2015 | 14:52PM EST
  6. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  7. Dynavax Secures $40 Million Credit Facility With Hercules Technology Growth Capital

    GuruFocus | Dec. 29, 2014 | 11:01AM EST
  8. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus | Dec. 23, 2014 | 14:47PM EST
  9. Dynavax Announces Webcast of R&D Day

    GuruFocus | Dec. 9, 2014 | 11:03AM EST
  10. Dynavax and AstraZeneca to Advance TLR9 Agonist for Treatment of Asthma Into Phase 2a Clinical Study

    GuruFocus | Dec. 8, 2014 | 15:02PM EST
  11. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  12. Dynavax Regains Full Rights to Investigational TLR 7/9 Inhibitor DV1179 Following Expiration of ...

    GuruFocus | Nov. 28, 2014 | 11:03AM EST
  13. Dynavax Announces Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM)

    GuruFocus | Nov. 10, 2014 | 11:07AM EST
  14. Dynavax Reports Third Quarter 2014 Financial Results

    GuruFocus | Nov. 5, 2014 | 11:06AM EST
  15. How To Quantify The Volatility Of Your Portfolio

    Benzinga | Oct. 22, 2014 | 10:03AM EST
  16. Dynavax Initiates Phase 1/2 Study of TLR-9 Agonist Immunotherapy in B-Cell Lymphoma

    GuruFocus | Oct. 15, 2014 | 12:50PM EST
  17. Two Promising Health Care Stocks with Market Capitalizations Under $500 Million

    GuruFocus | Jun. 11, 2014 | 14:16PM EST
  18. US Stock Futures Edge Higher Ahead Of Earnings

    Benzinga | Apr. 15, 2014 | 07:36AM EST
  19. Dynavax Initiates Phase 3 Study of HEPLISAV-B

    Benzinga | Apr. 15, 2014 | 07:12AM EST
  20. After-Hours Movers Mar. 5, 2014: ERII, PXLW, BIOD, SEED Higher, DVAX, LYV Lower

    Benzinga | Mar. 5, 2014 | 18:15PM EST
  21. Jefferies Reiterates on Dynavax Technologies Awaiting Initiation of HBV-23 Safety Trial

    Benzinga | Nov. 8, 2013 | 08:44AM EST
  22. Top Three Largest Insider Buys of the Past Week

    GuruFocus | Nov. 5, 2013 | 17:41PM EST
  23. Dynavax Issues Update on HEPLISAV's Regulatory Path, Will Host Call Tomorrow

    Benzinga | Oct. 16, 2013 | 17:10PM EST
  24. Dynavax Says Phase 3 Data on HEPLISAV for Adults Age 40-70 Published in VACCINE

    Benzinga | Sep. 24, 2013 | 16:01PM EST
  25. Insiders Are Buying Idera Pharmaceuticals

    GuruFocus | Sep. 19, 2013 | 19:33PM EST
  26. Mid-Afternoon Market Update: NuVasive Rises While EXCO Resourced Drops

    Benzinga | Jan. 9, 2013 | 08:52AM EST
  27. Mid-Day Market Update: Markets Remain Up, Dynavax Continues Rally

    Benzinga | Jan. 9, 2013 | 07:19AM EST
  28. Benzinga's Top Initiations

    Benzinga | Jan. 2, 2013 | 03:02AM EST
  29. Dynavax Bears Load Up on Put Options

    SchaeffersResearch | Dec. 31, 2012 | 12:44PM EST
  30. Benzinga's Top Pre-Market Losers

    Benzinga | Dec. 3, 2012 | 01:22AM EST
  31. Dynavax: Little Stock With a Big Story – Plunge a Buy Opportunity?

    YCharts | Nov. 19, 2012 | 04:47AM EST
  32. Mid-Afternoon Market Update: Markets Recovering; Penn National Gaming Still Up

    Benzinga | Nov. 16, 2012 | 09:04AM EST
  33. Mid-Day Markets Update: Markets Recover on Fiscal Cliff Meeting; Casino Stocks Continue to Ramp

    Benzinga | Nov. 16, 2012 | 06:10AM EST
  34. UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on Dynavax Technologies Corporation

    Benzinga | Nov. 16, 2012 | 05:22AM EST
  35. Mid-Morning Market Update: Markets Down; Casino Equities Get a Boost

    Benzinga | Nov. 16, 2012 | 03:36AM EST
  36. Mid-Afternoon Market Update: Markets Go Red; Ak Steel Plunges Again

    Benzinga | Nov. 13, 2012 | 08:29AM EST
  37. Benzinga's Top Initiations

    Benzinga | Nov. 6, 2012 | 00:37AM EST
  38. Dynavax Technologies Corp. Reports Operating Results (10-Q)

    GuruFocus | Nov. 2, 2012 | 13:08PM EST
  39. Dynavax to Initiate Phase 1 Studies For TLR-9 Agonist For Asthma

    Benzinga | Oct. 31, 2012 | 03:02AM EST
  40. Benzinga Mid-Morning Market Update

    Benzinga | Oct. 16, 2012 | 04:37AM EST
  41. Dynavax Tech Names Larson CFO

    Benzinga | Aug. 13, 2012 | 10:01AM EST
  42. Dynavax Technologies Corp. Reports Operating Results (10-Q)

    GuruFocus | Aug. 3, 2012 | 13:26PM EST
  43. Dynavax Prices Public Offering of Common Stock; 17.5M Shares at $4.25/Share

    Benzinga | May. 9, 2012 | 02:50AM EST
  44. Dynavax Initiates Proof of Mechanism Trial in Lupus Patients

    Benzinga | Dec. 20, 2011 | 02:06AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!